Contact us
Menu
Contact us

Feldan News

on Aug 28,2023

Feldan is proud to announce that it will receive advisory services and up to $563,000 in funding from the National Research Council Canada, Industrial Research Assistance Program (NRC- IRAP) for …

Read Story

on Jun 26,2023

Feldan is awarded an Applied Research and Development grant via the College and Community Innovation (CCI) program, for a total amount of $450,000. This funding will help develop Feldan Shuttle …

Read Story

on Jun 13,2023

Québec City, Canada, June 13, 2023 – Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, has announced the initial closing …

Read Story

on Apr 18,2023

MONTREAL, April 18, 2023 – CQDM is proud to announce the funding of a project worth $503,779 aiming at optimizing a new drug delivery platform in the lungs to treat …

Read Story

on Mar 20,2023

Feldan Therapeutics is pleased to share the promising results of FLD103 to treat basal cell carcinoma. A poster presented at the WCH23 Dermatology Conference last January (Intralesional Treatment of Basal …

Read Story

on Jan 18,2022

Quebec City, Canada, January 18, 2022 - Feldan Therapeutics, a biopharmaceutical company that develops therapeutics based on its proprietary intracellular delivery platform, announced today it was awarded funding by the …

Read Story

on Apr 14,2021

Read more on pages 54 to 57: BIOTECanada Insights sping 2021 …

Read Story

on Apr 7,2021

Congratulations to the team at NIH Common Fund’s Somatic Cell Genome Editing (SCGE) program for publishing their work in the journal Nature. Feldan is honoured to be part of this …

Read Story

on Feb 9,2021

Québec, Canada, February 9, 2021 – Feldan Therapeutics, a biotechnology company that develops therapeutics based on the intracellular delivery of proteins and peptides, announces the appointment of Dr. David J …

Read Story

on Jan 14,2021

Quebec City, Canada, January 14, 2021 – Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on the intracellular delivery of proteins and peptides, announces the creation …

Read Story